Come up with a name for your new list and we'll add to it:
Omrix raised a round of funding on November 25, 2008. Investors include
Johnson & Johnson.
Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix's biosurgery product line includes prod…